16 results on '"Stein, Mark A."'
Search Results
2. Editorial: Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Criminality: Commentary and Caution.
- Author
-
Stein, Mark A., Sibley, Margaret H., and Newcorn, Jeffrey H.
- Subjects
- *
ATTENTION-deficit hyperactivity disorder , *CRIMINAL behavior , *CRIME , *DELINQUENT behavior , *EXTERNALIZING behavior - Abstract
Pioneering longitudinal studies of boys with hyperactivity by Satterfield et al. 1 indicated that one of the most deleterious outcomes associated with attention-deficit/hyperactivity disorder (ADHD) is later antisocial behaviors. This risk grows when ADHD is accompanied by severe behavior problems.2 Though most children with ADHD will not go on to engage in criminal behavior, dimensional measures of externalizing behavior problems as well as categorical diagnoses of oppositional defiant disorder and conduct disorder have strong associations with ADHD. Moreover, cross-sectional studies of incarcerated adults indicate that 20% to 30% meet diagnostic criteria for ADHD.3 These associations between childhood ADHD, oppositional defiant disorder, and conduct disorder and later criminal behavior beg the question of whether treatment of ADHD can reduce the severity of, or in some cases prevent, criminal behavior. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Screening for parent and child ADHD in urban pediatric primary care: pilot implementation and stakeholder perspectives.
- Author
-
Lui, Joyce H. L., Danko, Christina M., Triece, Tricia, Bennett, Ian M., Marschall, Donna, Lorenzo, Nicole E., Stein, Mark A., and Chronis-Tuscano, Andrea
- Subjects
MEDICAL screening ,PEDIATRIC therapy ,PRIMARY care ,SOCIAL norms ,ATTENTION-deficit hyperactivity disorder - Abstract
Background: ADHD commonly co-occurs in children and parents. When ADHD is untreated in parents, it contributes to negative child developmental and treatment outcomes. Screening for parent and child ADHD co-occurrence in pediatric primary care may be an effective strategy for early identification and treatment. There is no data on whether this screening model can be implemented successfully and there exists limited guidance on how to effectively approach parents about their own ADHD in pediatric settings. Even greater sensitivity may be required when engaging with families living in urban, low SES communities due to systemic inequities, mistrust, and stigma. Methods: The current pilot study described the first 6 months of implementation of a parent and child ADHD screening protocol in urban pediatric primary care clinics serving a large population of families insured through Medicaid. Parents and children were screened for ADHD symptoms at annual well-child visits in pediatric primary care clinics as part of standard behavioral health screening. Independent stakeholder group meetings were held to gather feedback on factors influencing the implementation of the screening and treatment strategies. Mixed methods were used to examine initial screening completion rates and stakeholder perspectives (i.e., parents, primary care office staff, pediatricians, and behavioral health providers) on challenges of implementing the screening protocol within urban pediatric primary care. Results: Screening completion rates were low (19.28%) during the initial 6-month implementation period. Thematic analysis of stakeholder meetings provided elaboration on the low screening completion rates. Identified themes included: 1) divergence between provider enthusiasm and parent hesitation; 2) parent preference versus logistic reality of providers; 3) centering the experiences of people with marginalized identities; and 4) sensitivity when discussing parent mental health and medication. Conclusions: Findings highlight the importance of developing flexible approaches to screening parent and child ADHD in urban pediatric health settings and emphasize the importance of cultural sensitivity when working with marginalized and under-resourced families. Trial registration: NCT04240756 (27/01/2020). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Parent Behavior Management Training for Child ADHD Enhanced to Address Health Behaviors: Comparison of Telemedicine "Telegroup" Versus In-Person Delivery.
- Author
-
Gonzalez, Erin Schoenfelder, Tran, Nguyen, Wholly, Deirdre, Kuhn, Michelle, Stein, Mark A., Mendoza, Jason, Ola, Cindy, Sasser, Tyler, and Tandon, Pooja S.
- Subjects
PARENTING ,TRAINING of executives ,HEALTH behavior ,CAREGIVERS ,ATTENTION-deficit hyperactivity disorder ,TELEMEDICINE ,CO-sleeping - Abstract
Objective: ADHD is associated with suboptimal health behaviors including physical activity (PA). LEAP is a parent BMT group program enhanced to focus on health behaviors, integrated with mHealth technology. Little is known about implementing BMT via telemedicine "telegroups." Methods: Children ages 5 to 10 with ADHD and their caregiver wore activity trackers and participated in an 8 to 9 week parent BMT and social media group emphasizing PA, sleep, and screen use. A 7-day child accelerometer-wear and parent and teacher measures were completed pre- and post-group. Groups were in-person prior to the COVID-19 pandemic and in telegroup format during the pandemic. Results: Thirty-three families participated in person and 23 participated via virtual telegroup. Group attendance was superior for telegroup with equivalent satisfaction and skill use. Changes in health behavior and clinical outcomes were equivalent. Conclusions: LEAP is a feasible and novel BMT intervention that can be delivered in an accessible telegroup format with high participation and acceptability. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Conducting a Feedback Session.
- Author
-
Stein, Mark A. and Pearl, Phillip L.
- Subjects
- *
ASTHMA diagnosis , *TREATMENT of attention-deficit hyperactivity disorder , *LANGUAGE disorder diagnosis , *EDUCATION of parents , *PARENT attitudes , *ENURESIS , *MENTAL status examination , *ATTENTION-deficit hyperactivity disorder , *ACADEMIC achievement , *INTERPROFESSIONAL relations , *PATIENT-professional relations , *PATIENT education , *PARENT-child relationships , *CHILDREN - Abstract
The article informs about providing feedback after conducting a diagnostic evaluation is the most important activities a clinician can find extremely valuable to provide feedback to the pediatrician or referral source that helps maintain good communication for care and mental health services.
- Published
- 2022
- Full Text
- View/download PDF
6. Toward Precision Medicine in ADHD.
- Author
-
Buitelaar, Jan, Bölte, Sven, Brandeis, Daniel, Caye, Arthur, Christmann, Nina, Cortese, Samuele, Coghill, David, Faraone, Stephen V., Franke, Barbara, Gleitz, Markus, Greven, Corina U., Kooij, Sandra, Leffa, Douglas Teixeira, Rommelse, Nanda, Newcorn, Jeffrey H., Polanczyk, Guilherme V., Rohde, Luis Augusto, Simonoff, Emily, Stein, Mark, and Vitiello, Benedetto
- Subjects
INDIVIDUALIZED medicine ,ATTENTION-deficit hyperactivity disorder ,DRUG therapy - Abstract
Attention-Deficit Hyperactivity Disorder (ADHD) is a complex and heterogeneous neurodevelopmental condition for which curative treatments are lacking. Whilst pharmacological treatments are generally effective and safe, there is considerable interindividual variability among patients regarding treatment response, required dose, and tolerability. Many of the non-pharmacological treatments, which are preferred to drugtreatment by some patients, either lack efficacy for core symptoms or are associated with small effect sizes. No evidence-based decision tools are currently available to allocate pharmacological or psychosocial treatments based on the patient's clinical, environmental, cognitive, genetic, or biological characteristics. We systematically reviewed potential biomarkers thatmay help in diagnosing ADHD and/or stratifying ADHD into more homogeneous subgroups and/or predict clinical course, treatment response, and long-term outcome across the lifespan. Most work involved exploratory studies with cognitive, actigraphic and EEG diagnostic markers to predict ADHD, along with relatively few studies exploring markers to subtype ADHD and predict response to treatment. There is a critical need for multisite prospective carefully designed experimentally controlled or observational studies to identify biomarkers that index inter-individual variability and/or predict treatment response. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder.
- Author
-
Arnett, Anne B., Rutter, Tara M., and Stein, Mark A.
- Subjects
ATTENTION-deficit hyperactivity disorder ,METHYLPHENIDATE ,DRUG therapy ,AUDITORY neuropathy - Abstract
Background: Despite widespread use of stimulants to treat ADHD, individual responses vary considerably and few predictors of response have been identified. The identification of reliable and clinically feasible biomarkers would facilitate a precision medicine approach to pharmacological treatment of ADHD. We test the hypothesis that two electroencephalography (EEG) based neural signatures of ADHD, resting aperiodic slope exponent and novelty P3 amplitude, are markers of methylphenidate response in children. We hypothesize that positive response to methylphenidate treatment will be associated with greater abnormality of both neural markers. Methods: Twenty-nine 7-11 year-old children with ADHD and a history of methylphenidate treatment, and 30 controls completed resting EEG and visual oddball event related potential (ERP) paradigms. ADHD participants were characterized as methylphenidate responders (n = 16) or non-responders (n = 13) using the clinical global improvement (CGI-I) scale during blinded retrospective interview. All participants abstained from prescribed medications for at least 48 hours prior to the EEG. Results: As expected, methylphenidate responders (CGI-I rating < 3) demonstrated attenuated P3 amplitude relative to controls. Unexpectedly, methylphenidate non-responders showed atypically flat aperiodic spectral slope relative to controls, while responders did not differ on this measure. Conclusion: ADHD symptoms associated with atypical patterns of intrinsic neural activity may be less responsive to methylphenidate. In contrast, ADHD symptoms associated with abnormal frontal-striatal neural network excitation may be correctable with methylphenidate. Altogether, EEG is a feasible and promising candidate methodology for identifying biomarkers of stimulant response. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Reduced Glx and GABA Inductions in the Anterior Cingulate Cortex and Caudate Nucleus Are Related to Impaired Control of Attention in Attention-Deficit/Hyperactivity Disorder.
- Author
-
Mamiya, Ping C., Richards, Todd L., Edden, Richard A. E., Lee, Adrian K. C., Stein, Mark A., and Kuhl, Patricia K.
- Subjects
CONTROL (Psychology) ,ATTENTION control ,CAUDATE nucleus ,ATTENTION-deficit hyperactivity disorder ,CINGULATE cortex ,GABA - Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that impairs the control of attention and behavioral inhibition in affected individuals. Recent genome-wide association findings have revealed an association between glutamate and GABA gene sets and ADHD symptoms. Consistently, people with ADHD show altered glutamate and GABA content in the brain circuitry that is important for attention control function. Yet, it remains unknown how glutamate and GABA content in the attention control circuitry change when people are controlling their attention, and whether these changes can predict impaired attention control in people with ADHD. To study these questions, we recruited 18 adults with ADHD (31–51 years) and 16 adults without ADHD (28–54 years). We studied glutamate + glutamine (Glx) and GABA content in the fronto-striatal circuitry while participants performed attention control tasks. We found that Glx and GABA concentrations at rest did not differ between participants with ADHD or without ADHD. However, while participants were performing the attention control tasks, participants with ADHD showed smaller Glx and GABA increases than participants without ADHD. Notably, smaller GABA increases in participants with ADHD significantly predicted their poor task performance. Together, these findings provide the first demonstration showing that attention control deficits in people with ADHD may be related to insufficient responses of the GABAergic system in the fronto-striatal circuitry. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Editorial: Treating Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children With Stimulants: Modest Effects in Young Children With Big Problems.
- Author
-
Stein, Mark A.
- Subjects
- *
ATTENTION-deficit hyperactivity disorder , *READINESS for school , *STIMULANTS , *MEDICAL screening , *PEDIATRICIANS , *CENTRAL nervous system stimulants , *BEHAVIOR , *COMORBIDITY - Abstract
Poor school readiness and high rates of expulsion from preschool or day care are common in very young children with attention-deficit/hyperactivity disorder (ADHD), while in cases of severe impulsivity and inadequate monitoring there is real danger of injury to the child and others. Compared to older children, preschool-age children with ADHD have more frequent and often severe ADHD symptoms and high rates of psychiatric and developmental comorbidity.1 As pediatricians are now routinely screening for ADHD in children as young as 4 years of age,2 identification will likely increase. However, once identified, far less is known about treating ADHD.3. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Home direct-to-consumer telehealth solutions for children with mental health disorders and the impact of Covid-19.
- Author
-
Norman, Sierra, Atabaki, Shireen, Atmore, Kathleen, Biddle, Cara, DiFazio, Marc, Felten, Daniel, Fox, Eduardo, Marschall, Donna, Newman, Julie, Robb, Adelaide, Rowland, Cecilia, Selekman, Rachel, Slovin, Ariella, Stein, Mark, Strang, John, and Sable, Craig
- Subjects
TERTIARY care ,ATTENTION-deficit hyperactivity disorder ,HEALTH insurance reimbursement ,AUTISM ,DESCRIPTIVE statistics ,ANXIETY ,TELEMEDICINE ,MENTAL illness ,COVID-19 pandemic - Abstract
Delivery of mental health treatment in the home can close gaps in care. Telehealth also provides access to healthcare that has been disrupted due to the COVID-19 pandemic. In 2016, a home direct-to-consumer telehealth program was initiated. Mental health encounters made up a significant portion of all telehealth encounters and COVID-19 had a significant impact on accelerating the utilization of telehealth. Telemental health has been more successful at meeting targeted volumes than the overall health system. Of all the mental health diagnoses before and during COVID-19, attention deficit hyperactivity disorder, Autism Spectrum Disorder, and Anxiety Disorder were most common. The direct-to-consumer telehealth program saved patients a significant amount of travel miles and associated time, based on data from the period before COVID-19. Payment reimbursement for direct-to-consumer telehealth professional services was similar to reimbursement for in-person visits. This program demonstrates direct-to-consumer telehealth is a feasible and acceptable care modality for a variety of youth mental health disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. 41.1 Understanding the Impact of ADHD Familiality and Genetics on ADHD Medication Response and Optimization.
- Author
-
Stein, Mark A.
- Subjects
- *
ATTENTION-deficit hyperactivity disorder , *GENETICS , *DRUGS - Published
- 2023
- Full Text
- View/download PDF
12. Evaluating the Feasibility and Acceptability of the Lifestyle Enhancement for ADHD Program.
- Author
-
Ola, Cindy, Gonzalez, Erin, Tran, Nguyen, Sasser, Tyler, Kuhn, Michelle, LaCount, Patrick A, Stein, Mark A, Mendoza, Jason A, and Tandon, Pooja S
- Subjects
ATTENTION-deficit hyperactivity disorder ,PARENTING ,PARENTING education ,HEALTH behavior ,TRAINING of executives - Abstract
Objective: To evaluate the feasibility and acceptability of the Lifestyle Enhancement for Attention Deficit Hyperactivity Disorder (ADHD) Program (LEAP), a novel parent behavior management training program that promotes physical activity (PA) and positive health behaviors and is enhanced with mobile health technology (Garmin) and a social media (Facebook) curriculum for parents of children with ADHD.Methods: The study included parents of children ages 5-10 years diagnosed with ADHD who did not engage in the recommended >60 min/day of moderate to vigorous PA based on parent report at baseline. Parents participated in the 8-week LEAP group and joined a private Facebook group. Children and one parent wore wrist-worn Garmin activity trackers daily. Parents completed the Treatment Adherence Inventory, Client Satisfaction Questionnaire, and participated in a structured focus group about their experiences with various aspects of the program.Results: Of 31 children enrolled, 51.5% had ADHD combined presentation, 36.3% with ADHD, predominately inattentive presentation, and 12.1% had unspecified ADHD (age 5-10; M = 7.6; 48.4% female). Parents attended an average of 86% of group sessions. On average, parents wore their Garmins for 5.1 days/week (average step count 7,092 steps/day) and children for 6.0 days/week (average step count 9,823 steps/day). Overall, parents and children were adherent to intervention components and acceptability of the program was high.Conclusions: Findings indicate that the LEAP program is an acceptable and feasible intervention model for promoting PA among parents and their children with ADHD. Implications for improving ADHD symptoms and enhancing evidence-based parent training programs are discussed. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
13. Editorial: Longitudinal Associations Between Sleep and ADHD Symptoms: ADHD Is a 24-Hour Disorder.
- Author
-
Stein, Mark A. and Weiss, Margaret D.
- Subjects
- *
SLEEP quality , *ATTENTION-deficit hyperactivity disorder , *SYMPTOMS , *SLEEP , *CROSS-sectional method - Abstract
There is a robust literature of predominantly cross-sectional studies demonstrating an association between attention-deficit/hyperactivity disorder (ADHD) and sleep quality in childhood and adolescence, measured by subjective as well as objective measures, dimensional and categorical variables, and controlling for a wide range of confounders such as other disorders.1 Moreover, ADHD symptoms and sleep problems are independently associated with adverse functional outcome and quality of life.2 As a result, these are viewed as common and mutually exacerbating conditions, likely mediated by common neuropathways.3-5. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. MANAGING ADOLESCENTS WITH ADHD: DEVELOPMENTAL ISSUES, EMERGING COMORBIDITY, AND THE IMPACT OF COVID-19.
- Author
-
Stein, Mark A. and Rostain, Anthony Leon
- Subjects
- *
COVID-19 , *ATTENTION-deficit hyperactivity disorder , *COMORBIDITY , *TEENAGERS - Published
- 2021
- Full Text
- View/download PDF
15. Predictors of Treatment Engagement and Outcome Among Adolescents With Attention-Deficit/Hyperactivity Disorder: An Integrative Data Analysis.
- Author
-
Sibley, Margaret H., Coxe, Stefany J., Stein, Mark A., Meinzer, Michael C., and Valente, Matthew J.
- Subjects
- *
ATTENTION-deficit hyperactivity disorder , *TREATMENT effectiveness , *BEHAVIOR therapy , *DATA analysis , *GRADE point average , *TREATMENT of attention-deficit hyperactivity disorder , *RESEARCH , *RESEARCH methodology , *EVALUATION research , *COMPARATIVE studies , *RESEARCH funding , *PARENTS - Abstract
Objective: To identify patient- and treatment-level factors that predict intervention engagement and outcome for adolescents with attention-deficit/hyperactivity disorder (ADHD), guiding efforts to enhance care.Method: Integrative data analysis was used to pool data from 4 randomized controlled trials of adolescent ADHD treatment with participants (N = 854) receiving various evidence-based behavioral therapy packages in 5 treatment arms (standard [STANDARD], comprehensive [COMP], engagement-focused [ENGAGE]), community-based usual care (UC), or no treatment (NOTX). Participants also displayed varying medication use patterns (negligible, inconsistent, consistent) during the trial. Regression and latent growth curve analyses examined treatment- and patient-level predictors of engagement and outcome.Results: Compared with COMP, ENGAGE was associated with higher parent engagement in behavioral therapy (d = 1.35-1.73) when delivered in university, but not community, clinics. Under some conditions, ENGAGE also predicted youth engagement in behavioral therapy (d = 1.21) and lower likelihood of negligible medication use (odds ratio = 0.49 compared with NOTX). UC was associated with poorer parent engagement compared with COMP (d = -0.59) and negligible medication use (odds ratio = 2.29) compared with NOTX. Compared with COMP, ENGAGE (in university settings) was consistently associated with larger ADHD symptom improvements (d = 0.41-0.83) at 6-month follow-up and sometimes associated with larger grade point average (d = 0.68) and parent-teen conflict (d = 0.41) improvements. Consistent medication use during behavioral therapy was associated with larger improvements in ADHD symptoms (d = 0.28) and parent-teen conflict (d = 0.25-0.36). An ADHD+internalizing clinical profile predicted larger improvements in grade point average (d = 0.45). Family adversity predicted poorer parent and youth engagement (rate ratio = 0.90-0.95), negligible medication use (odds ratio = 1.22), and smaller improvements in grade point average (d = -0.23). African American race predicted smaller improvements in parent-teen conflict (d = -0.49).Conclusion: Engagement-focused behavioral therapy and consistent medication use most frequently predicted stronger clinical engagement and outcomes for adolescents with ADHD. Youths who are African American or who experience family adversity may demonstrate treatment-related disparities for certain outcomes; youths with ADHD+internalizing symptoms may demonstrate excellent academic outcomes following behavioral therapy.Data Sharing: The full ADHD TIDAL dataset is publicly available through the National Data Archive (https://nda.nih.gov), including a data dictionary. The study protocol is also publicly available: https://doi.org/10.1186/s12888-020-02734-6. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
- Author
-
Faraone, Stephen V., Banaschewski, Tobias, Coghill, David, Zheng, Yi, Biederman, Joseph, Bellgrove, Mark A., Newcorn, Jeffrey H., Gignac, Martin, Al Saud, Nouf M., Manor, Iris, Rohde, Luis Augusto, Yang, Li, Cortese, Samuele, Almagor, Doron, Stein, Mark A., Albatti, Turki H., Aljoudi, Haya F., Alqahtani, Mohammed M.J., Asherson, Philip, and Atwoli, Lukoye
- Subjects
- *
INTERNATIONAL organization , *ATTENTION-deficit hyperactivity disorder , *ADULTS , *PUBLICATION bias , *TREATMENT delay (Medicine) - Abstract
• ADHD occurs in 5.9 % of youth and 2.5 % of adults. • Most cases of ADHD are caused by the combined effects of many genetic and environmental risks. • There are small differences in the brain between people with and without ADHD. • Untreated ADHD can lead to many adverse outcomes. • ADHD costs society hundreds of billions of dollars each year, worldwide. Misconceptions about ADHD stigmatize affected people, reduce credibility of providers, and prevent/delay treatment. To challenge misconceptions, we curated findings with strong evidence base. We reviewed studies with more than 2000 participants or meta-analyses from five or more studies or 2000 or more participants. We excluded meta-analyses that did not assess publication bias, except for meta-analyses of prevalence. For network meta-analyses we required comparison adjusted funnel plots. We excluded treatment studies with waiting-list or treatment as usual controls. From this literature, we extracted evidence-based assertions about the disorder. We generated 208 empirically supported statements about ADHD. The status of the included statements as empirically supported is approved by 80 authors from 27 countries and 6 continents. The contents of the manuscript are endorsed by 366 people who have read this document and agree with its contents. Many findings in ADHD are supported by meta-analysis. These allow for firm statements about the nature, course, outcome causes, and treatments for disorders that are useful for reducing misconceptions and stigma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.